Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
163,926,065
-
Total 13F shares
-
155,771,786
-
Share change
-
+27,199,370
-
Total reported value
-
$1,970,400,036
-
Put/Call ratio
-
132%
-
Price per share
-
$12.65
-
Number of holders
-
204
-
Value change
-
+$381,733,655
-
Number of buys
-
146
-
Number of sells
-
64
Institutional Holders of Dyne Therapeutics, Inc. - COMMON STOCK (DYN) as of Q3 2025
As of 30 Sep 2025 Dyne Therapeutics, Inc. - COMMON STOCK (DYN) had 204 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 155,771,786 shares of stock of the company.
Largest 10 holders included JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, BlackRock, Inc., Atlas Venture Life Science Advisors, LLC, FCPM III SERVICES B.V., FMR LLC, STATE STREET CORP, Siren, L.L.C., TCG Crossover Management, LLC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This table shows 204 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.